Summary
Clinical and biochemical data obtained from 163 patients who had taken an overdose of paracetamol were examined to determine which factors or measurements were of value in predicting the severity of ensuing liver damage early after ingestion of tablets. Although the overall severity of hepatic necrosis was found to increase with the dose of paracetamol ingested, correlation was not sufficiently close to provide an accurate prognostic index in individuals. Severe hepatic damage was less likely if the patient had vomited or had a stomach wash-out within 6 hr of overdose. The plasma concentrations of paracetamol, measured at known times after overdose, distinguished those who developed hepatic dysfunction from those who did not, but there was a poor correlation, particularly in the first 6 hr after ingestion of tablets, between these values and the severity of ensuing liver damage. Estimates of early plasma paracetamol half-lives from three or more samples taken within 4 hr of admission showed that all patients developing moderate or severe liver damage had half-lives greater than 4 hr, but this was also the case in nearly one-third of those with minimal liver lesions only. Population Census, 1975) . Unlike most other drugs taken in overdose, the toxic effects of paracetamol may not be observed for several days (Clark et al., 1973) .
Jollow and his colleagues were the first to show that damage to the liver was produced by a reactive intermediate of paracetamol, and it was then shown that this could be prevented by agents containing sulphydryl groups (Mitchell et al., 1974) . Prescott and his colleagues (Prescott et al., 1974) subsequently reported that one such substance cysteamine (mercaptamine) was of value in man, although its use is accompanied by abdominal cramps, vomiting, and drowsiness. As the compound has to be given as soon as possible after the overdose (Mitchell et al., 1974) Kistler and Scherle, 1966) . The number of points on the graticule which coincided with a viable hepatocyte were counted in sixty high power fields. The fraction of the total area occupied by liver cells could then be calculated, and this was proportional to the hepatocyte volume fraction (HVF).
The plasma concentrations of unconjugated paracetamol were estimated, using the absorbence of the drug at 250 nm after its extraction into ether (Dordoni et al., 1973) . The samples were all analysed within 1 hr of being taken. An absorption spectrum between 200 and 350 nm was also obtained in most of the patients using a Pye Unicam SP 800 spectrophotometer. In thirty-three patients plasma levels of paracetamol were also determined by gas liquid chromatography (Prescott, 1971 ). In fifty-six patients three or more samples were obtained at timed intervals over a period of 4 hr after admission. The initial plasma disappearance time for paracetamol was estimated from the results plotted on semi-logarithmic graph paper.
Plasma solutions of a number of other drugs commonly taken in overdose, with similar absorption spectra to paracetamol which are extracted into ether and therefore could potentially interfere with the spectrophotometric assay, were made up in the maximum concentrations found in the plasma of patients after overdose, and the pH was adjusted to 7-4. These were then extracted into ether in the same way as for the paracetamol estimation, and the ultraviolet absorption spectrum was obtained by scanning between wavelengths 200 and 350 nm using the SP 800 spectrophotometer. In addition, the optical density was measured for each drug at 250 nm. The degree of interference with the paracetamol assay was expressed as the 'apparent paracetamol concentration' obtained by relating the absorbence to the standard curve for paracetamol.
Results
The patients were separated into three categories according to the severity of the ensuing liver damage, on the basis of the maximum serum bilirubin levels described by Clark et (Table 2 ). When the outcome was considered in relation to the dose of paracetamol claimed to have been ingested, some correlation with the severity of liver damage could be detected. The chances of developing severe liver damage was less in those patients who had vomited or had a stomach wash-out within 6 hr of drug ingestion (twelve of seventy-one) than in those who had not (seventeen of forty-six, X2 = 6-91, P < 0-05).
The investigation into the potential interference of other drugs commonly taken in overdose with the spectrophotometric assay for paracetamol showed that only high plasma concentrations of dichloralphenazone and, to a much lesser extent, phenobarbital, were likely to interfere significantly (Table TABLE 1 3). A highly significant correlation was found between measurements of plasma unconjugated paracetamol levels by the ether extraction method and by gas liquid chromatography (n = 33, r = 0-98, P < 0-001). When plasma paracetamol concentrations were plotted on a semi-logarithmic scale against time after ingestion of tablets, all patients who developed moderate or severe hepatic damage had levels falling on or above a line joining values of 180 ,tg/ml at 4 hr and 45 ,ug/ml at 12 hr (Fig. 1) Similarly, although estimates of the initial plasma half-life of paracetamol were generally higher in patients who developed the more extensive liver damage, there was considerable overlap for individual values (Fig. 2) . Thus, although plasma halflives of 4 hr or longer were found in all patients who subsequently developed moderate or severe hepatic necrosis, such prolongation was also found in eight of the twenty-eight patients classified as having minimal liver lesions. Furthermore, of the twenty patients in this series who died the only one who was admitted early enough for determination of paracetamol half-life had a value well below the maximum recorded for the severe group (Fig. 2) .
Discussion
Experimental studies in animals have shown paracetamol to be a dose-related hepatotoxin . and this is also probably true in man (Davis et al., 1976) . In the present series there was an overall correlation between the number of tablets ingested and the degree of ensuing liver damage, but this was not sufficiently precise to be of prognostic value in individual cases. One likely reason for this is that estimates of drug ingestion by acutely distressed self-poisoned patients are not always accurate (Matthew, 1971 ) despite careful history taking. Indeed, in one-third of the patients in the present series, this information could not be obtained. Furthermore, the quantity of drug absorbed from the gastrointestinal tract must vary widely from individual to individual (Rowland et al., 1972) depending on whether the patient vomits or has a stomach wash-out early after the overdose, and certainly, in the present study, either of these two events significantly reduced the degree of liver damage. This is likely to complicate interpretation of the results of treatment with mercaptamine, although in neither of the trials reported with this drug to date has the possible influence of early vomiting or gastric lavage been acknowledged (Prescott et al., 1974; Douglas et al., 1976) .
If plasma levels of paracetamol are to be of early prognostic help a rapid technique for measuring the drug is clearly essential. The method of ultra-violet absorption after ether extraction from plasma used in the present study provides results within 15 min and, although the technique is not specific for paracetamol, the results correlated well with the more time-consuming gas liquid chromatographic method. The possible interference in the assay by other compounds with similar absorption spectra was investigated because in 25% of suicidal overdoses more than one drug is involved (Chambers, 1976 (Kendal, Lloyd-Jones and Smith, 1976; Widdop, 1976) (Prescott et al., 1974; Douglas et al., 1976 ). The difficulty is that patients may not accurately recall the exact time they took the overdose, particularly when sedative drugs or large quantities of alcohol have also been ingested. Furthermore, in the present series, plasma paracetamol concentrations correlated poorly with the degree of ensuing hepatocellular damage for individual subjects and the prognostic value of these estimates was particularly poor when measurements were made within 6 hr of overdose. Thus, as the results of the present study indicate, about 25% of patients selected for mercaptamine treatment on the basis of a single plasma paracetamol level will be at risk from trivial hepatic damage only, and if cases seen within 6 hr are considered, up to one third may be treated unnecessarily.
